CheckMate 012: Safety and efficacy of first-line (1L) nivolumab (nivo; N) and ipilimumab (ipi; I) in advanced (adv) NSCLC Meeting Abstract
| Authors: | Hellmann, M. D.; Gettinger, S. N.; Goldman, J. W.; Brahmer, J. R.; Borghaei, H.; Chow, L. Q.; Ready, N.; Gerber, D. E.; Juergens, R. A.; Shepherd, F. A.; Laurie, S. A.; Zhou, Y.; Geese, W. J.; Agrawal, S.; Li, X.; Antonia, S. J. |
| Abstract Title: | CheckMate 012: Safety and efficacy of first-line (1L) nivolumab (nivo; N) and ipilimumab (ipi; I) in advanced (adv) NSCLC |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 142s |
| Language: | English |
| ACCESSION: | WOS:000404665404041 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.3001 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3001 -- Source: Wos |
